soul trial oral semaglutide cardiovascular outcomes results 2025 In patients with cardiometabolic #HFpEF, #semaglutide and #tirzepatide reduced the risk of hospitalization for heart failure or all-cause mortality compared to sitagliptin, but tirzepatide offered no additional benefit over semaglutide. #ESCCongress Cardiovascular Outcomes, Safety, and Tolerability

It works for injectable GLP-1s Wegovy, Zepbound, Ozempic, Mounjaro, semaglutide, tirzepatide, and compounded forms and for oral GLP-1s including Rybelsus, oral Wegovy, Foundayo, and orforglipron

The Wegovy pill and all currently available injectable versions of the drug are peptides, or short chains of amino acids, that are similar to the bodys GLP-1, whereas Foundayo is a nonpeptide small molecule

Gastrointestinal adverse effects represent the most frequent challenge during GLP-1 therapy, affecting up to 40-50% of patients to varying degrees

Normal Biological Functions NAD and glutathione systems are essential for life and are well characterized in biochemistry, physiology, and disease research

doi: 10.1016/j.physbeh.2010.02.029 18 AlhadeffALRupprechtLEHayesMR